Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-10 Sale |
2022-02-11 4:05 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,832 | $27.84 | $134,523 | 159,913 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:22 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
798 | $26.51 | $21,152 | 54,114 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:20 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,350 | $27.4 | $36,990 | 100,988 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:19 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,125 | $27.4 | $30,825 | 102,435 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:18 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,125 | $27.4 | $30,825 | 124,497 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:17 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
1,238 | $27.4 | $33,921 | 95,055 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:16 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,813 | $27.4 | $131,876 | 372,145 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:38 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
934 | $24.58 | $22,955 | 28,662 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:37 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,875 | $24.98 | $46,838 | 36,520 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:36 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,875 | $24.98 | $46,838 | 58,582 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:35 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
2,250 | $24.98 | $56,205 | 35,298 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:34 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
2,063 | $24.98 | $51,534 | 29,253 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:33 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
7,873 | $24.98 | $196,668 | 131,710 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-12 4:07 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
5,000 | $27.4 | $137,000 | 37,548 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-12 4:06 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
2,500 | $27.4 | $68,500 | 38,395 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-12 4:05 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
7,500 | $27.4 | $205,500 | 31,316 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:03 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,332 | $30.08 | $521,407 | 139,583 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 4:08 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
31,800 | $29.39 | $934,602 | 149,494 (Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $26.23 | $262,300 | 251,294 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
8,500 | $29.69 | $252,400 | 181,294 (Indirect Direct) |
View |
| 2021-10-07 Sale |
2021-10-08 4:18 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
60,000 | $26.25 | $1,574,760 | 269,794 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 4:06 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,058 | $24.77 | $75,746 | 60,457 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:41 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,407 | $17.12 | $24,086 | 63,515 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:40 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
7,836 | $17.12 | $134,142 | 156,915 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:39 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,407 | $17.12 | $24,085 | 47,614 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:38 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,407 | $17.12 | $24,085 | 35,731 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:35 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,407 | $17.12 | $24,086 | 37,548 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:34 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
1,407 | $17.12 | $24,085 | 31,316 (Direct) |
View |
| 2021-07-28 Sale |
2021-07-29 4:09 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,250 | $13.81 | $17,263 | 44,521 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-11 Option Award |
2022-05-12 8:26 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
12,000 | $0 | 79,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:24 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
12,000 | $0 | 49,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:22 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director |
12,000 | $0 | 47,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:20 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director |
12,000 | $0 | 20,250 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:18 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
12,000 | $0 | 29,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:22 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
26,250 | $0 | 54,114 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:20 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
67,040 | $0 | 100,988 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:19 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
67,040 | $0 | 102,435 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:18 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
67,040 | $0 | 124,497 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:17 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
67,040 | $0 | 95,055 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:16 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
245,248 | $0 | 372,145 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 4:07 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
5,000 | $0 | 37,548 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 4:06 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
5,000 | $0 | 38,395 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
7,500 | $0 | 31,316 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 6:09 pm |
N/A 2032-12-31 |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $16.23 | 251,294 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 4:05 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $0 | 251,294 (Direct) |
View |
| 2021-02-04 Gift |
2021-11-03 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
28,000 | $0 | 181,294 (Direct) |
View |
| 2021-10-07 Exercise |
2021-10-08 4:18 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
60,000 | $16.23 | 269,794 (Direct) |
View |
| 2021-10-07 Exercise |
2021-10-08 4:18 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
60,000 | $0 | 269,794 (Direct) |
View |
Ownership |
2021-09-23 6:14 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
0 | $0 | 136,254 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 6:16 pm |
N/A 2031-09-13 |
Travere Therapeutics Inc. | TVTX | Brinkley Ruth Williams Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:41 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
4,500 | $0 | 63,515 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:40 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,500 | $0 | 156,915 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:39 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
4,500 | $0 | 47,614 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:38 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
4,500 | $0 | 35,731 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:35 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
4,500 | $0 | 37,548 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:34 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,500 | $0 | 31,316 (Direct) |
View |